Stephen Bloch, MD is a General Partner at Canaan Partners, where he invests across seed to late-stage ventures in biopharma, digital health, medical devices, and diagnostics. He invests primarily in the United States, including the Northeast (East Coast, New England, Connecticut). He serves on the board of Liquidia Corporation and has invested in companies like Liquidia Corporation, Advanced BioHealing, Amicus Therapeutics, Marinus Pharmaceuticals, and Ambra Health. Before Canaan, he was Chief Executive Officer of Radiology Management Sciences and a consultant at Arthur D. Little. Stephen studied at the University of Rochester School of Medicine and Dentistry and resides in the United States.
Stephen Bloch, MD, General Partner @ Canaan. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Stephen Bloch, MD from EvolveImmune Therapeutics. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Stephen
Map your path to Stephen instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Stephen
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.